Stem Cell Patent Dispute Stayed Until PTO Ruling
Biotechnology company StemCells Inc. has agreed to halt a patent suit brought against rival Neuralstem Inc. while the U.S. Patent and Trademark Office reevaluates the four patents-in-suit, the company said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article